CareDx director granted 9,795 RSUs
Cohen Fred E reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cohen Fred E reported acquisition or exercise transactions in this Form 4 filing.
CareDx, Inc. director Fred E. Cohen received an equity grant of 9,795 shares of Common Stock in the form of restricted stock units. These RSUs vest 100% on the earlier of one year from the grant date or the day before the first Annual Meeting after the grant date, subject to his continuous service. Following this award, he holds 165,060 shares directly.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 9,795 | $0.00 | $0.00 |
Footnotes (1)
- F1. The reported securities are represented by restricted stock units ("RSUs"), of which the RSUs vests 100% on the earlier of the one year anniversary of grant or the day immediately before the first Annual Meeting that occurs after the grant date., subject to the Reporting Person's continuous service on each applicable vesting date.
Key Figures
Key Terms
restricted stock units financial
RSUs financial
Annual Meeting financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did CareDx (CDNA) report for Fred E. Cohen?
What are the vesting terms of Fred E. Cohen’s new RSUs at CareDx (CDNA)?
Is Fred E. Cohen’s CareDx (CDNA) transaction a market buy or sell?
AI-generated analysis. How Rhea-AI works. Not financial advice.